Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin-D as Adjuvant to Phototherapy in Neonatal Hyperbilirubinemia
NCT07098234Completed
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of vitamin d in hyperbilirubinemia (2 arms). Primary endpoint: Bilirubin reduction comparison at 72 hours. Started Jul 2022; status: completed.
02
Drugs
vitamin d
03
Conditions
hyperbilirubinemia
Beyond the preview
Go deeper on NCT07098234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07098234.